{"id":"https://openalex.org/W2031155689","doi":"https://doi.org/10.1097/fpc.0b013e32834c6edb","title":"Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in The Rotterdam Study","display_name":"Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in The Rotterdam Study","alternate_titles":[],"publication_year":2011,"publication_date":"2011-10-04","ids":{"openalex":"https://openalex.org/W2031155689","doi":"https://doi.org/10.1097/fpc.0b013e32834c6edb","mag":"2031155689","pmid":"https://pubmed.ncbi.nlm.nih.gov/21946898"},"language":"en","primary_location":{"id":"doi:10.1097/fpc.0b013e32834c6edb","doi":"https://doi.org/10.1097/fpc.0b013e32834c6edb","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fpc.0b013e32834c6edb","pdf_url":null,"source":{"id":"https://openalex.org/S192301155","display_name":"Pharmacogenetics and Genomics","issn_l":"1744-6872","issn":["1744-6872","1744-6880"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics and Genomics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2031155689"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057687580","display_name":"Laure Elens","orcid":"https://orcid.org/0000-0002-0039-3583","observed_orcids":["https://orcid.org/0000-0002-0039-3583"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laure Elens","raw_affiliation_strings":["Departments of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands","Universit\u00e9 catholique de Louvain, Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Bruxelles, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Universit\u00e9 catholique de Louvain, Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Bruxelles, Belgium","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015817939","display_name":"Matthijs L. Becker","orcid":"https://orcid.org/0000-0003-0054-7498","observed_orcids":["https://orcid.org/0000-0003-0054-7498"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthijs L. Becker","raw_affiliation_strings":["Epidemiology","Hospital Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology","institution_ids":[]},{"raw_affiliation_string":"Hospital Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051216300","display_name":"Vincent Haufroid","orcid":"https://orcid.org/0000-0001-5040-9806","observed_orcids":["https://orcid.org/0000-0001-5040-9806"]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vincent Haufroid","raw_affiliation_strings":["Universit\u00e9 catholique de Louvain, Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Bruxelles, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 catholique de Louvain, Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Bruxelles, Belgium","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039611937","display_name":"Albert Hofman","orcid":"https://orcid.org/0000-0002-9865-121X","observed_orcids":["https://orcid.org/0000-0002-9865-121X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Albert Hofman","raw_affiliation_strings":["Epidemiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058099822","display_name":"Loes E. Visser","orcid":"https://orcid.org/0000-0002-1421-6246","observed_orcids":["https://orcid.org/0000-0002-1421-6246"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Loes E. Visser","raw_affiliation_strings":["Epidemiology","Hospital Pharmacy","Internal Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology","institution_ids":[]},{"raw_affiliation_string":"Hospital Pharmacy","institution_ids":[]},{"raw_affiliation_string":"Internal Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031530236","display_name":"Andr\u00e9 Gerardus Uitterlinden","orcid":"https://orcid.org/0000-0002-7276-3387","observed_orcids":["https://orcid.org/0000-0002-7276-3387"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andr\u00e9 G. Uitterlinden","raw_affiliation_strings":["Epidemiology","Internal Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology","institution_ids":[]},{"raw_affiliation_string":"Internal Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007319489","display_name":"Bruno H. Ch. Stricker","orcid":"https://orcid.org/0000-0003-3713-9762","observed_orcids":["https://orcid.org/0000-0003-3713-9762"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Bruno Ch. Stricker","raw_affiliation_strings":["Epidemiology","Internal Medicine","Medical Informatics, Erasmus Medical Center","to Bruno Ch. Stricker, PhD, Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands Tel: +31 10 7033119; fax: +31 10 4367894; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +31 10 4367894","to Bruno Ch. Stricker, PhD, Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands Tel: +31 10 7033119"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology","institution_ids":[]},{"raw_affiliation_string":"Internal Medicine","institution_ids":[]},{"raw_affiliation_string":"Medical Informatics, Erasmus Medical Center","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"to Bruno Ch. Stricker, PhD, Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands Tel: +31 10 7033119; fax: +31 10 4367894; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +31 10 4367894","institution_ids":[]},{"raw_affiliation_string":"to Bruno Ch. Stricker, PhD, Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands Tel: +31 10 7033119","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112254985","display_name":"Ron H. N. van Schaik","orcid":"https://orcid.org/0000-0003-1864-2151","observed_orcids":["https://orcid.org/0000-0003-1864-2151"]},"institutions":[{"id":"https://openalex.org/I4210152231","display_name":"Star Medisch Diagnostisch Centrum","ror":"https://ror.org/04jfsvb44","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210152231"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ron H.N. van Schaik","raw_affiliation_strings":["Departments of Clinical Chemistry","STAR Medical Diagnostic Center, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Chemistry","institution_ids":[]},{"raw_affiliation_string":"STAR Medical Diagnostic Center, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210152231"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5007319489"],"corresponding_institution_ids":["https://openalex.org/I2801952686"],"apc_list":null,"apc_paid":null,"fwci":10.5075,"has_fulltext":false,"cited_by_count":131,"citation_normalized_percentile":{"value":0.99470064,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"21","issue":"12","first_page":"861","last_page":"866"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.02160000056028366,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.984000027179718},{"id":"https://openalex.org/keywords/cyp3a4-22","display_name":"CYP3A4*22","score":0.9419999718666077},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lipid-lowering-effect","display_name":"hypolipidemic effect","score":0.7749999761581421},{"id":"https://openalex.org/keywords/total-cholesterol","display_name":"total cholesterol","score":0.753000020980835},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9070000052452087},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.49399998784065247},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.6380000114440918},{"id":"https://openalex.org/keywords/rotterdam-study","display_name":"Rotterdam Study","score":0.7820000052452087},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.4090000092983246},{"id":"https://openalex.org/keywords/confounding","display_name":"confounding","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.8714844584465027},{"id":"https://openalex.org/C153209595","wikidata":"https://www.wikidata.org/wiki/Q501128","display_name":"Single-nucleotide polymorphism","level":4,"score":0.7697174549102783},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.5547053217887878},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.5214897394180298},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5039710402488708},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49503985047340393},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4914129972457886},{"id":"https://openalex.org/C139275648","wikidata":"https://www.wikidata.org/wiki/Q17134011","display_name":"SNP","level":5,"score":0.46586349606513977},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46323534846305847},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.42035606503486633},{"id":"https://openalex.org/C37463918","wikidata":"https://www.wikidata.org/wiki/Q387981","display_name":"Allele frequency","level":4,"score":0.41594916582107544},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.2707573175430298},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22871220111846924},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.1483229696750641},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12278109788894653},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.1034809947013855},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000483","descriptor_name":"Alleles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007438","descriptor_name":"Introns","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1097/fpc.0b013e32834c6edb","doi":"https://doi.org/10.1097/fpc.0b013e32834c6edb","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fpc.0b013e32834c6edb","pdf_url":null,"source":{"id":"https://openalex.org/S192301155","display_name":"Pharmacogenetics and Genomics","issn_l":"1744-6872","issn":["1744-6872","1744-6880"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics and Genomics","raw_type":"journal-article"},{"id":"pmid:21946898","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21946898","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics and genomics","raw_type":"Journal Article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/52c0158b-9953-4b1d-bff4-dbfb10603521","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/52c0158b-9953-4b1d-bff4-dbfb10603521","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Elens, L, Becker, M, Haufroid, V, Hofman, B, Visser, L, Uitterlinden, A, Stricker, BC & van Schaik, R 2011, 'Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in The Rotterdam Study', Pharmacogenetics and Genomics, vol. 21, no. 12, pp. 861-866. https://doi.org/10.1097/FPC.0b013e32834c6edb","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/52c0158b-9953-4b1d-bff4-dbfb10603521","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/52c0158b-9953-4b1d-bff4-dbfb10603521","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacogenetics Genomics, 21(12), 861 - 866. Lippincott Williams &amp; Wilkins","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:106380","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/106380","pdf_url":null,"source":{"id":"https://openalex.org/S4306401902","display_name":"Digital Access to Libraries (Universit\u00e9 catholique de Louvain (UCL), l'Universit\u00e9 de Namur (UNamur) and the Universit\u00e9 Saint-Louis (USL-B))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I95674353","host_organization_name":"UCLouvain","host_organization_lineage":["https://openalex.org/I95674353"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacogenetics and Genomics, Vol. 21, no. 12, p. 861-6 (2011)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1557641267","https://openalex.org/W1833888881","https://openalex.org/W1885786785","https://openalex.org/W1964331471","https://openalex.org/W1966846971","https://openalex.org/W1969054950","https://openalex.org/W1976358806","https://openalex.org/W1983283139","https://openalex.org/W1994350860","https://openalex.org/W1994691874","https://openalex.org/W2000093141","https://openalex.org/W2005776262","https://openalex.org/W2017098712","https://openalex.org/W2018126221","https://openalex.org/W2019635687","https://openalex.org/W2051922899","https://openalex.org/W2068639674","https://openalex.org/W2070128988","https://openalex.org/W2071124826","https://openalex.org/W2072288084","https://openalex.org/W2073213000","https://openalex.org/W2075597058","https://openalex.org/W2080228333","https://openalex.org/W2085551183","https://openalex.org/W2085942677","https://openalex.org/W2090876589","https://openalex.org/W2105902511","https://openalex.org/W2106343349","https://openalex.org/W2109252993","https://openalex.org/W2125573444","https://openalex.org/W2126655119","https://openalex.org/W2127736404","https://openalex.org/W2139823003","https://openalex.org/W2150140189","https://openalex.org/W2155673450","https://openalex.org/W2156920144","https://openalex.org/W4211231996","https://openalex.org/W4244900749"],"related_works":["https://openalex.org/W2016814341","https://openalex.org/W4285490970","https://openalex.org/W2146501267","https://openalex.org/W2065163772","https://openalex.org/W2108799014","https://openalex.org/W2984725735","https://openalex.org/W1971854626","https://openalex.org/W2022800946","https://openalex.org/W1995419786","https://openalex.org/W2075597058"],"abstract_inverted_index":{"OBJECTIVES:":[0],"CYP3A4":[1,30,72,212],"is":[2,232],"involved":[3],"in":[4,36,54,80,116,139,174,215,244],"the":[5,14,41,68,71,113,131,165,171,236,239],"oxidative":[6],"metabolism":[7],"of":[8,21,43,63,238,241,254],"many":[9],"drugs":[10],"and":[11,78,89,119,141,151,181,247],"xenobiotics":[12],"including":[13],"HMG-CoA":[15],"reductase":[16],"inhibitor":[17],"simvastatin.":[18],"The":[19,96,201],"objective":[20],"this":[22],"study":[23],"was":[24,83,99,176,208],"to":[25,221,251],"investigate":[26],"whether":[27],"a":[28,55,61,102,105,216,233],"new":[29],"functional":[31],"single":[32],"nucleotide":[33],"polymorphism":[34],"(SNP)":[35],"intron":[37,73,203],"6":[38,74,204],"(CYP3A4*22)":[39],"modifies":[40],"effect":[42],"simvastatin":[44,66,107,255],"on":[45],"total":[46,62],"cholesterol":[47,51,81],"(TOTc)":[48],"or":[49],"LDL":[50],"(LDLc)":[52],"reduction":[53,79,115,138,173],"population-based":[56],"cohort":[57],"study.":[58],"METHODS:":[59],"In":[60],"80":[64],"incident":[65],"users,":[67],"association":[69],"between":[70],"C>T":[75],"SNP":[76,205],"(rs35599367)":[77],"levels":[82,121],"analyzed":[84],"using":[85],"linear":[86],"regression":[87],"analysis":[88],"adjusting":[90],"for":[91,167,182,190,227],"potential":[92,168],"confounding":[93,169,228],"factors.":[94,229],"RESULTS:":[95],"CYP3A4*22":[97,132,191,202],"allele":[98,133,192,207],"associated":[100,209],"with":[101,124,159,196,210],"trend":[103],"towards":[104,235],"stronger":[106],"lipid-lowering":[108],"response,":[109],"as":[110],"reflected":[111],"by":[112],"greater":[114,189],"both":[117],"TOTc":[118,140,175],"LDLc":[120,183],"when":[122,157,194,223],"compared":[123,158,195],"homozygous":[125,160],"wild":[126,198],"type.":[127,199],"We":[128],"observed":[129],"that":[130],"carriers":[134,193],"had":[135],"an":[136],"increased":[137],"LDLc:":[142],"-0.25":[143],"mmol/l":[144,153,178,185],"(95%":[145],"confidence":[146],"interval":[147],"[CI(95%)]=[-0.52;":[148],"0.01],":[149,155],"P=0.058)":[150],"-0.29":[152],"(CI(95%)=[-0.58;":[154],"P=0.054)":[156],"CC.":[161],"When":[162],"we":[163],"adjusted":[164,226],"model":[166],"factors,":[170],"corresponding":[172],"-0.31":[177],"(CI(95%)=[-0.59;-0.04],":[179],"P=0.028)":[180],"-0.34":[184],"(CI(95%)=[-0.66;":[186],"-0.02],":[187],"P=0.034)":[188],"homozygotes":[197],"CONCLUSION:":[200],"T-variant":[206],"reduced":[211],"activity,":[213],"resulting":[214],"better":[217],"lipid":[218],"lowering":[219],"response":[220,246],"simvastatin,":[222],"data":[224],"were":[225],"This":[230],"observation":[231],"step":[234],"clarification":[237],"reasons":[240],"interindividual":[242],"variability":[243],"statins":[245],"may":[248],"potentially":[249],"lead":[250],"improved":[252],"tailoring":[253],"therapy.":[256]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2031155689","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":26},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
